1.Association of lipoprotein particles with cardiovascular risk in diabetes
Chinese Journal of Endocrinology and Metabolism 2013;29(9):820-823
Type 2 diabetic patients are usually accompanied by dyslipidemia.The cardiovascular residual risk is still high in these patients,even with glycemia,blood pressure,and plasma lipids well controlled.In this review,the relationship of plasma lipids and changes in lipoprotein particles with cardiovascular risk is discussed.
2.Pancreas transplantation for diabetes mellitus
Chinese Journal of Endocrinology and Metabolism 2012;28(1):85-88
Diabetes mellitus impacts patient survival and quality of life mainly due to its acute and chronic complications.Pancreas transplantation may restore normoglycemia and reduce the complication of insulin-dependent diabetes,thus improving the quality of life and prolonging patient's survival.Although pancreas transplantation requires major surgery and life-long immunosuppression therapy,it currently remains the gold stand for patients with type 1 diabetes mellitus,who do not respond to conventional therapy.Meanwhile,potential of the islet transplantation,insulin-producing cells replacement therapy,and artificial pancreas as the alternative to pancreas transplantation are under investigation.
3.Metabolism of amino acids and type 2 diabetes mellitus
Chinese Journal of Endocrinology and Metabolism 2012;28(9):773-776
Amino acids (AA) as substrates of gluconeogenesis could promote endogenous glucose production.Some AA can enhance insulin secretion. Recently,many studies have found that some AA can also activate mammalian target of rapamycin-S6 kinase 1 ( mTOR-S6K1 ) pathway,resulting in maintaining pancreatic β cell function on one hand,and on the other hand,inhibiting insulin signal transduction of insulin-sensitive cells and thus causing insulin resistance.
4.Plasma levels of cortisol, free fatty acids and their relationships to insulin resistance in patients with type 2 diabetes
Chinese Journal of Endocrinology and Metabolism 1986;0(03):-
Fasting free fatty acids (FFA), plasma cortisol (F) were determined in newly diagnosed patients with type 2 diabetes. The results show that FFA, F and HOMA-IR are significantly higher in patients with type 2 diabetes than those in controls(all P
5.Effects of fenofibrate and pioglitazone on expressions of intracellular signaling molecules in pancreatic islet of high-fat diet-fed rats
Ting FENG ; Bo YANG ; Haoming TIAN
Chinese Journal of Endocrinology and Metabolism 2008;24(4):416-419
Objective To observe the effects of fenofibrate and pioglitazone on the expressions of PPAR- α, PPAR-γ, and intracellular signaling molecules in pancreatic islets of obese rats induced by high-fat diets. Methods SD obese rat models were established with high-fat diet, and 40 male rats were assigned to 4 groups including high-fat diet (HF group), high-fat diet with fenofibrate (FF group), pioglitazone (FP group) treatment, and control rats with normal diet (NC group). After 8 weeks intervention, immunohistochemistry was performed to evaluate the expressions of various proteins in islets; At the same time, islets mass were scored in tissue slides. Results Islets mass enlarged in HF group. The compositions of islet cells were the same as the control. The expression of insulin was lower in HF group than the control, but after using pioglitazone, less islets mass and more insulin expression were found in FP group. Compared with the control group, expressions of PPAR-α, PPAR-γ protein were reduced in HF group, and the expression of PPAR-α protein increased in FF group, and the expression of PPAR-γ protein was increased in FP group. The levels of NF-кB, p38 mitogen-activated protein kinase (MAPK), ERK1 proteins increased significantly in HF group, the expressions of NF-кB, p38 MAPK decreased in FF and FP groups, and the level of ERK1 decreased only in FP group, the protein level of I-кB showed no difference among control, HF group, and FF groups. Conclusion Fenofibrate and pioglitazone may partially protect islet cells function and improve survival by correcting the disturbance of intracellular signaling molecules.
6.The effects of gender and obesity on plasma leptin,NPY,TNF-? in type 2 diabetes mellitus
Rui HAN ; Haoming TIAN ; Nanwei TONG
Chinese Journal of Diabetes 1994;0(01):-
In type 2 diabetes mellitus,the levels of leptin were higher in female and obese subjects compared with male and non-obese subjects.There was negative relationship in female between leptin and HbA_1c,and negative relationship between leptin and HDL-C in male.Gender and obesity had no effect on TNF-? and NP Y.
7.A RANDOMIZED CONTROL STUDY OF GEMFIBROZIL AND PANTETHINE ON ANTI-LIPID-PEROZIDATON IN DIABETES MELLITUS
Nan-Wei TONG ; Jinzhong LIANG ; Haoming TIAN ;
Chinese Journal of Endocrinology and Metabolism 1986;0(04):-
Randomized control study of gemfibrozil and pantethine was made in 39 NIDDM patients to compare their effect on anti-lipid-peroxidation.The patients were divided into two groups at random. One group took gcmfibrozil 900 mg/d for 4 weeks, the ether group took pantethine 540 mg/d for 4 weeks. The results showed that there were no significant change in faslirg plasma glucose and HbA1 in both groups before and after treatment. The effects on lipicls and lipcproteins in gemfi-barozil and pantethine groups were as follows: TC decreased by 18.15% and 8.75% (P
8.A study on blood lipids and apolipoproteins in type 2 diabetic patients and their normoglycemic first-degree relatives in Chinese type 2 diabetic pedigrees
Lingchuan HAN ; Haoming TIAN ; Yan REN ; Xiujun LI ; Jianan WANG
Chinese Journal of Endocrinology and Metabolism 2000;0(06):-
Objective To investigate the clinical significance of changes in lipids and apolipoproteins (Apo) in type 2 diabetic patients and their normoglycemic first-degree relatives (NFDR). Methods Triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), ApoAⅠ, ApoB_ 100 , ApoCⅢ and ApoE were determined in 62 type 2 diabetic patients and 67 NFDR from 29 Chinese type 2 diabetic pedigrees as well as 45 normoglycemic controls without family history of diabetes (NC) in Chengdu city, China. Results (1)TG level was higher in type 2 diabetic patients 〔(1.85?1.31)mmol/L〕 as compared with those in NFDR 〔(1.39?0.91)mmol/L〕 and NC 〔(0.92?0.45)mmol/L〕, and TG level in NFDR was higher as compared with that in NC (all P
10.Effect of pioglitazone treatment on components of serum free fatty acid in type 2 diabetic patients
Ting FENG ; Bo YANG ; Xiangxun ZHANG ; Jianwei LI ; Hongling YU ; Haoming TIAN
Chinese Journal of Endocrinology and Metabolism 2008;24(2):178-179
Components of free fatty acids (FFA) were examined by reverse high performance liquid chromatography in 25 patients with type 2 diabetes and 25 control subjects.The changes in components of FFA were observed before treatment, at 3 months and 1 year after treatment with pioglitazone in type 2 diabetic patients.The serum lauric acid, myristic acid and stearic acid levels were much higher in the diabetic patients than those in control subjects.Pioglitazone could decrease the levels of these fatty acids in the patients with type 2 diabetes mellitus.